{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:11:45Z","timestamp":1794629505161,"version":"4.9.1"},"reference-count":23,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although peripheral blood stem cells (PBSCs) have replaced bone marrow (BM) as the most common unrelated donor progenitor cell product collected, a direct comparison of concurrent PBSC versus BM donation experiences has not been performed. We report a prospective study of 2726 BM and 6768 PBSC donors who underwent collection from 2004 to 2009. Pain and toxicities were assessed at baseline, during G-CSF administration, on the day of collection, within 48 hours of donation, and weekly until full recovery. Peak levels of pain and toxicities did not differ between the 2 donation processes for most donors. Among obese donors, PBSC donors were at increased risk of grade 2 to 4 pain as well as grade 2 to 4 toxicities during the pericollection period. In contrast, BM donors were more likely to experience grade 2 to 4 toxicities at 1 week and pain at 1 week and 1 month after the procedure. BM donors experienced slower recovery, with 3% still not fully recovered at 24 weeks, whereas 100% of PBSC donors had recovered. Other factors associated with toxicity included obesity, increasing age, and female sex. In summary, this study provides extensive detail regarding individualized risk patterns of PBSC versus BM donation toxicity, suggesting donor profiles that can be targeted with interventions to minimize toxicity.<\/jats:p>","DOI":"10.1182\/blood-2012-03-417667","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T05:27:22Z","timestamp":1351574842000},"page":"197-206","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":128,"title":["Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program"],"prefix":"10.1182","volume":"121","author":[{"given":"Michael A.","family":"Pulsipher","sequence":"first","affiliation":[{"name":"Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pintip","family":"Chitphakdithai","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent R.","family":"Logan","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwen E.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Anthony Nolan Research Institute, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Wingard","sequence":"additional","affiliation":[{"name":"LifeSouth Community Blood Centers, Gainesville, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillard M.","family":"Lazarus","sequence":"additional","affiliation":[{"name":"University Hospitals Case Medical Center, Ireland Cancer Center, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K.","family":"Waller","sequence":"additional","affiliation":[{"name":"Emory University Hospital, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Seftel","sequence":"additional","affiliation":[{"name":"CancerCare Manitoba, University of Manitoba, Winnipeg, MB;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Stroncek","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Lopez","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipnarine","family":"Maharaj","sequence":"additional","affiliation":[{"name":"Bethesda Health City, Boynton Beach, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiman","family":"Hematti","sequence":"additional","affiliation":[{"name":"University of Wisconsin Hospital and Clinics, Madison, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul V.","family":"O'Donnell","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison W.","family":"Loren","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia. PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan F.","family":"Leitman","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Anderlini","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"The University of Michigan, Ann Arbor, MI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Levine","sequence":"additional","affiliation":[{"name":"The University of Michigan, Ann Arbor, MI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willis H.","family":"Navarro","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"},{"name":"National Marrow Donor Program, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Miller","sequence":"additional","affiliation":[{"name":"National Marrow Donor Program, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Confer","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"},{"name":"National Marrow Donor Program, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111809510427400_B1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbmt.2008.05.018","article-title":"Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.","volume":"14","author":"Miller","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111809510427400_B2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/bmt.2010.37","article-title":"Unrelated hematopoietic stem cell donors as research subjects.","volume":"46","author":"King","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111809510427400_B3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/bmt.2010.2","article-title":"Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.","volume":"45","author":"Shaw","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"15","key":"2019111809510427400_B4","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1182\/blood-2008-08-175323","article-title":"Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.","volume":"113","author":"Pulsipher","year":"2009","journal-title":"Blood"},{"issue":"21","key":"2019111809510427400_B5","article-title":"Health-related quality-of-life among adult matched unrelated stem cell donors: a Blood and Marrow Transplant Clinical Trials Network (BMT CTN) randomized trial of marrow versus PBSC donation [abstract].","volume":"116","author":"Switzer","year":"2010","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"2019111809510427400_B6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"2019111809510427400_B7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"issue":"9","key":"2019111809510427400_B8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1704245","article-title":"Differences between graft product and donor side effects following bone marrow or stem cell donation.","volume":"32","author":"Favre","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111809510427400_B9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbmt.2004.02.003","article-title":"An evaluation of the donor experience in the Canadian multicenter randomized trial of bone marrow versus peripheral blood allografting.","volume":"10","author":"Bredeson","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2019111809510427400_B10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bmt.1703338","article-title":"Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study.","volume":"29","author":"Fortanier","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111809510427400_B11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.bmt.1703418","article-title":"Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints.","volume":"29","author":"Heldal","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2019111809510427400_B12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.bmt.1704053","article-title":"Impact of stem cell donation modality on normal donor quality of life: a prospective randomized study.","volume":"31","author":"Kennedy","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2019111809510427400_B13","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood.V97.9.2541","article-title":"Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation.","volume":"97","author":"Rowley","year":"2001","journal-title":"Blood"},{"issue":"1","key":"2019111809510427400_B14","first-page":"CD006406","article-title":"Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors.","author":"Siddiq","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2019111809510427400_B15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.bmt.1702072","article-title":"Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.","volume":"25","author":"Cavallaro","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2019111809510427400_B16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/sj.bmt.1703693","article-title":"Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development.","volume":"30","author":"Anderlini","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2019111809510427400_B17","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood.V95.9.2993.009k40a_2993_2994","article-title":"Normal T, B, and NK cell counts in healthy donors at 1 year after blood stem cell harvesting.","volume":"95","author":"Storek","year":"2000","journal-title":"Blood"},{"issue":"12","key":"2019111809510427400_B18","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1111\/j.1537-2995.2010.02781.x","article-title":"Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donors.","volume":"50","author":"Marmier-Savet","year":"2010","journal-title":"Transfusion"},{"issue":"9","key":"2019111809510427400_B19","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/j.1537-2995.2008.01788.x","article-title":"Hematopoietic growth factors\u2013use in normal blood and stem cell donors: clinical and ethical issues.","volume":"48","author":"McCullough","year":"2008","journal-title":"Transfusion"},{"issue":"7","key":"2019111809510427400_B20","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1537-2995.2008.01694.x","article-title":"The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors.","volume":"48","author":"Pamphilon","year":"2008","journal-title":"Transfusion"},{"issue":"4","key":"2019111809510427400_B21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pbc.20708","article-title":"Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.","volume":"46","author":"Pulsipher","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2019111809510427400_B22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2007.06524.x","article-title":"Long-term safety of filgrastim (rhG-CSF) administration.","volume":"137","author":"Confer","year":"2007","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111809510427400_B23","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood-2007-12-130179","article-title":"Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4\/SDF-1 interaction.","volume":"112","author":"Devine","year":"2008","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/1\/197\/1362768\/zh800113000197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/1\/197\/1362768\/zh800113000197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T21:44:01Z","timestamp":1714513441000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/1\/197\/31035\/Acute-toxicities-of-unrelated-bone-marrow-versus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-03-417667","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,3]]}}}